Discontinuation report CYCLOMEN
| Report ID | 247771 |
| Drug Identification Number | 02018144 |
| Brand name | CYCLOMEN |
| Common or Proper name | Danazol |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DANAZOL |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | Blister |
| ATC code | G03XA |
| ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2025-07-31 |
| Actual discontinuation date | 2025-07-31 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Company business decision |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-08-01 | English | Compare |
| v6 | 2025-07-31 | French | Compare |
| v5 | 2025-07-31 | English | Compare |
| v4 | 2025-07-31 | French | Compare |
| v3 | 2025-07-31 | English | Compare |
| v2 | 2025-01-15 | French | Compare |
| v1 | 2025-01-15 | English | Compare |
Showing 1 to 7 of 7